Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Age-associated Cardiac and Vascular Dysfunction Through Nrf2 Signaling Using the Nutritional Supplement Sulforaphane

NCT05408559 is registered in ClinicalTrials.gov with Texas Tech University Health Sciences Center as lead sponsor.

NCT NCT05408559
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05408559 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Age-associated Cardiac and Vascular Dysfunction Through Nrf2 Signaling Using the Nutritional Supplement Sulforaphane
Lead sponsor
Texas Tech University Health Sciences Center
Phase
Phase 1/2
Overall status
Withdrawn
Start date
July 1, 2022
Completion date
January 1, 2026
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diastolic dysfunction, diastolic heart failure, systolic dysfunction